skip to main content
Idioma:
previous page 1 Resultados 2 3 4 5 next page
Refinado por: Base de dados/Biblioteca: Gale Academic OneFile Select remover Base de dados/Biblioteca: Springer Nature - Springer Journals All 2022 remover IngentaConnect Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I–IIIB breast cancer receiving chemotherapy
Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I–IIIB breast cancer receiving chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I–IIIB breast cancer receiving chemotherapy

van den Berg, Maaike M. G. A. ; Kok, Dieuwertje E. ; Posthuma, Liesbeth ; Kamps, Lisette ; Kelfkens, Celine S. ; Buist, Nicole ; Geenen, Maud ; Haringhuizen, Annebeth ; Heijns, Joan B. ; van Lieshout, Rianne H. M. A. ; Los, Maartje ; Sommeijer, Dirkje W. ; Timmer-Bonte, Johanna N. H. ; de Kruif, Anja Th. C. M. ; van Laarhoven, Hanneke W. M. ; Kampman, Ellen ; Winkels, Renate M.

Breast cancer research and treatment, 2019-01, Vol.173 (2), p.475-481 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
12
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab

Lin, Nancy U. ; Winer, Eric P. ; Wheatley, Duncan ; Carey, Lisa A. ; Houston, Stephen ; Mendelson, David ; Munster, Pamela ; Frakes, Laurie ; Kelly, Steve ; Garcia, Agustin A. ; Cleator, Susan ; Uttenreuther-Fischer, Martina ; Jones, Hilary ; Wind, Sven ; Vinisko, Richard ; Hickish, Tamas

Breast cancer research and treatment, 2012-06, Vol.133 (3), p.1057-1065 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
13
Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy
Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy

Glück, Stefan ; de Snoo, Femke ; Peeters, Justine ; Stork-Sloots, Lisette ; Somlo, George

Breast cancer research and treatment, 2013-06, Vol.139 (3), p.759-767 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
14
Molecularly targeted therapies for metastatic triple-negative breast cancer
Molecularly targeted therapies for metastatic triple-negative breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Molecularly targeted therapies for metastatic triple-negative breast cancer

Bayraktar, Soley ; Glück, Stefan

Breast cancer research and treatment, 2013-02, Vol.138 (1), p.21-35 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
15
Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)
Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)

Dekker, T. J. A. ; van de Velde, C. J. H. ; van Pelt, G. W. ; Kroep, J. R. ; Julien, J-P. ; Smit, V. T. H. B. M. ; Tollenaar, R. A. E. M. ; Mesker, W. E.

Breast cancer research and treatment, 2013-06, Vol.139 (2), p.371-379 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
16
STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells
STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells

Jafari, Sevda ; Lavasanifar, Afsaneh ; Hejazi, Mohammad Saied ; Maleki-Dizaji, Nasrin ; Mesgari, Mehran ; Molavi, Ommoleila

Daru, 2020-06, Vol.28 (1), p.159-169 [Periódico revisado por pares]

Cham: Springer International Publishing

Texto completo disponível

Citações Citado por
17
Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer
Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer

Sørensen, Kristina P. ; Thomassen, Mads ; Tan, Qihua ; Bak, Martin ; Cold, Søren ; Burton, Mark ; Larsen, Martin J. ; Kruse, Torben A.

Breast cancer research and treatment, 2013-12, Vol.142 (3), p.529-536 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
18
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)
Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)

Miles, David ; Baselga, José ; Amadori, Dino ; Sunpaweravong, Patrapim ; Semiglazov, Vladimir ; Knott, Adam ; Clark, Emma ; Ross, Graham ; Swain, Sandra M.

Breast cancer research and treatment, 2013-11, Vol.142 (1), p.89-99 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
19
Breast cancer characteristics and HIV among 1,092 women in Soweto, South Africa
Breast cancer characteristics and HIV among 1,092 women in Soweto, South Africa
Material Type:
Artigo 		Adicionar ao Meu Espaço

Breast cancer characteristics and HIV among 1,092 women in Soweto, South Africa

Cubasch, Herbert ; Joffe, Maureen ; Hanisch, Rachel ; Schuz, Joachim ; Neugut, Alfred I. ; Karstaedt, Alan ; Broeze, Nadine ; van den Berg, Eunice ; McCormack, Valerie ; Jacobson, Judith S.

Breast cancer research and treatment, 2013-07, Vol.140 (1), p.177-186 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
20
Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages
Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages

Alkhateeb, Ahmed A. ; Han, Bing ; Connor, James R.

Breast cancer research and treatment, 2013-02, Vol.137 (3), p.733-744 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por
previous page 1 Resultados 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1993  (30)
  2. 1993Até2000  (106)
  3. 2001Até2008  (35)
  4. 2009Até2017  (661)
  5. Após 2017  (184)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (1.014)
  2. Japonês  (126)
  3. Russo  (4)
  4. Português  (3)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.